24 March, 2021
The third year of iPC project has started and in order to present the current work that each consortium partner is developing, we asked them to summarize the processes that are being done behind the project. This week we present the XLAB company (Slovenia) where Jolanda Modic explains the current work that they are developing within iPC:
“XLAB is contributing to the development of the iPC platform and exploring opportunities for its wide exploitation beyond the scope of the project. In this sense, XLAB is working on different machine learning methods to improve image-based cancer diagnostics and thereby support the development of effective personalized therapies and treatments for kids with cancer.”